BlackRock’s Gain Therapeutics GANX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $203K | Buy |
112,507
+28,100
| +33% | +$50.6K | ﹤0.01% | 4598 |
|
|
2025
Q1 | $161K | Sell |
84,407
-1,654
| -2% | -$3.16K | ﹤0.01% | 4596 |
|
|
2024
Q4 | $186K | Buy |
86,061
+1,137
| +1% | +$2.46K | ﹤0.01% | 4578 |
|
|
2024
Q3 | $151K | Buy |
84,924
+304
| +0.4% | +$541 | ﹤0.01% | 4537 |
|
|
2024
Q2 | $108K | Buy |
84,620
+9,222
| +12% | +$11.8K | ﹤0.01% | 4633 |
|
|
2024
Q1 | $284K | Buy |
75,398
+47,787
| +173% | +$180K | ﹤0.01% | 4456 |
|
|
2023
Q4 | $90.2K | Sell |
27,611
-314
| -1% | -$1.03K | ﹤0.01% | 4759 |
|
|
2023
Q3 | $91.6K | Sell |
27,925
-1,099
| -4% | -$3.61K | ﹤0.01% | 4801 |
|
|
2023
Q2 | $130K | Buy |
29,024
+4,246
| +17% | +$19K | ﹤0.01% | 4753 |
|
|
2023
Q1 | $119K | Sell |
24,778
-202
| -0.8% | -$974 | ﹤0.01% | 4833 |
|
|
2022
Q4 | $78.2K | Buy |
24,980
+2,079
| +9% | +$6.51K | ﹤0.01% | 5032 |
|
|
2022
Q3 | $75K | Sell |
22,901
-640
| -3% | -$2.1K | ﹤0.01% | 5171 |
|
|
2022
Q2 | $85K | Buy |
23,541
+12,904
| +121% | +$46.6K | ﹤0.01% | 5186 |
|
|
2022
Q1 | $43K | Sell |
10,637
-522
| -5% | -$2.11K | ﹤0.01% | 5354 |
|
|
2021
Q4 | $60K | Sell |
11,159
-317
| -3% | -$1.7K | ﹤0.01% | 5304 |
|
|
2021
Q3 | $85K | Sell |
11,476
-183
| -2% | -$1.36K | ﹤0.01% | 5111 |
|
|
2021
Q2 | $116K | Buy |
+11,659
| New | +$116K | ﹤0.01% | 4938 |
|